The clinical information you need, at your fingertips.

Medical News for You

Proc Natl Acad Sci

Tick exposure shifts earlier in warm years, but not longer

The calendar for tick-borne illness suspicion may need to move up, and the cues clinicians and patients rely on for a bad tick year turn out not to predict much. . .

Pediatrics

36m

Early flu antivirals linked to markedly fewer pediatric hospitalizations

Starting antiviral treatment within 48 hours of symptom onset was associated with a substantially lower risk of influenza-related hospitalization in children. . .

Ann Intern Med

Repeat heart marker test may sharpen CV risk in older adults

Older adults whose elevated cardiac marker levels later fell back into range ended up with risks resembling people who were never elevated at all. . .

FDA

Lerochol gains FDA approval for autoinjector, offering easier once-monthly PCSK9 option

FDA clears a self-administered autoinjector for lerodalcibep-liga and updates labeling to reflect the established cardiovascular benefits of LDL-C reduction. . .

JAMA Intern Med

Most US adults lack immunity to hepatitis A or B

National survey data reveal large immunity gaps, even among those at elevated risk for severe disease. . .

CDC

Kindergarten vaccination fell, as policy now shifts

Coverage remains high nationally, but 2025-2026 declines were broad and exemptions rose in most states. The White House recently weighed in. . .

JAMA Intern Med

Shoulder pain? Most patients may not need a scan

New review urges primary care clinicians to prioritize reassurance, activity modification, and watchful waiting over routine scans and procedures. . .

JAMA

ED patients can wait hours for inpatient team takeover

Being admitted is not the same as being managed, and current boarding measures do not track the difference. . .

CDC

CDC warns of severe arboviral disease risk with B cell-depleting therapies

As West Nile virus activity accelerates in 2026, CDC highlights increased risk of severe neuroinvasive arboviral infections in patients receiving anti-CD20 and other B cell-targeted therapies. . .